Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Journal of Medicinal Chemistry
|
November 18, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists
Md Toufiqur Rahman, Ann M Decker, Tiffany L Langston, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS
|
February 4, 2026
A Pharmacokinetic and Efficacy Study of FDA-Indexed Pharmaceutical-Grade Extended-Release Buprenorphine and Compounded Sustained-Release Buprenorphine in African Green Monkeys (Chlorocebus aethiops)
Tracy J Brown, Trinity Rudd, Robert C diTargiani, et al.
Journal of Medicinal Chemistry
|
December 20, 2021
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior
Thuy Nguyen, Thomas F Gamage, David B Finlay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 15, 2009
Meaning behind measurement: self-comparisons affect responses to health-related quality of life questionnaires
Clare Robertson, Anne L Langston, Sally Stapley, et al.
Journal of Medicinal Chemistry
|
August 10, 2017
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
Thuy Nguyen, Nadezhda German, Ann M Decker, et al.
ACS Chemical Neuroscience
|
September 7, 2018
Diarylureas Containing 5-Membered Heterocycles as CB<sub>1</sub> Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation
Thuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
BMC Health Services Research
|
May 31, 2008
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
Anne L Langston, Marie Johnston, Jill Francis, et al.
Plos One
|
December 2, 2017
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
M D Raleigh, S J Peterson, M Laudenbach, et al.
Frontiers in Physiology
|
August 5, 2017
Aging in Rats Differentially Affects Markers of Transcriptional and Translational Capacity in Soleus and Plantaris Muscle
Christopher B Mobley, Petey W Mumford, Wesley C Kephart, et al.
Nature Genetics
|
May 4, 2010
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone
Omar M E Albagha, Micaela R Visconti, Nerea Alonso, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Journal of Medicinal Chemistry
|
November 18, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists
Md Toufiqur Rahman, Ann M Decker, Tiffany L Langston, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS
|
February 4, 2026
A Pharmacokinetic and Efficacy Study of FDA-Indexed Pharmaceutical-Grade Extended-Release Buprenorphine and Compounded Sustained-Release Buprenorphine in African Green Monkeys (Chlorocebus aethiops)
Tracy J Brown, Trinity Rudd, Robert C diTargiani, et al.
Journal of Medicinal Chemistry
|
December 20, 2021
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior
Thuy Nguyen, Thomas F Gamage, David B Finlay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 15, 2009
Meaning behind measurement: self-comparisons affect responses to health-related quality of life questionnaires
Clare Robertson, Anne L Langston, Sally Stapley, et al.
Journal of Medicinal Chemistry
|
August 10, 2017
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
Thuy Nguyen, Nadezhda German, Ann M Decker, et al.
ACS Chemical Neuroscience
|
September 7, 2018
Diarylureas Containing 5-Membered Heterocycles as CB<sub>1</sub> Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation
Thuy Nguyen, Thomas F Gamage, Ann M Decker, et al.
BMC Health Services Research
|
May 31, 2008
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
Anne L Langston, Marie Johnston, Jill Francis, et al.
Plos One
|
December 2, 2017
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
M D Raleigh, S J Peterson, M Laudenbach, et al.
Frontiers in Physiology
|
August 5, 2017
Aging in Rats Differentially Affects Markers of Transcriptional and Translational Capacity in Soleus and Plantaris Muscle
Christopher B Mobley, Petey W Mumford, Wesley C Kephart, et al.
Nature Genetics
|
May 4, 2010
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone
Omar M E Albagha, Micaela R Visconti, Nerea Alonso, et al.
Page
of 6